BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30120157)

  • 1. Impact of Guideline-Discordant Treatment on Cost and Health Care Utilization in Older Adults with Early-Stage Breast Cancer.
    Williams CP; Kenzik KM; Azuero A; Williams GR; Pisu M; Halilova KI; Ingram SA; Yagnik SK; Forero A; Bhatia S; Rocque GB
    Oncologist; 2019 Jan; 24(1):31-37. PubMed ID: 30120157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concordance with NCCN treatment guidelines: Relations with health care utilization, cost, and mortality in breast cancer patients with secondary metastasis.
    Rocque GB; Williams CP; Kenzik KM; Jackson BE; Azuero A; Halilova KI; Ingram SA; Pisu M; Forero A; Bhatia S
    Cancer; 2018 Nov; 124(21):4231-4240. PubMed ID: 30317547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Nonconcordance With NCCN Guidelines on Resource Utilization, Cost, and Mortality in De Novo Metastatic Breast Cancer.
    Rocque GB; Williams CP; Jackson BE; Ingram SA; Halilova KI; Pisu M; Kenzik KM; Azuero A; Forero A; Bhatia S
    J Natl Compr Canc Netw; 2018 Sep; 16(9):1084-1091. PubMed ID: 30181420
    [No Abstract]   [Full Text] [Related]  

  • 4. Guideline Discordance and Patient Cost Responsibility in Medicare Beneficiaries With Metastatic Breast Cancer.
    Williams CP; Azuero A; Kenzik KM; Pisu M; Nipp RD; Bhatia S; Rocque GB
    J Natl Compr Canc Netw; 2019 Oct; 17(10):1221-1228. PubMed ID: 31590153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of guideline-concordant initial systemic treatment with clinical and economic outcomes among older women with metastatic breast cancer in the United States.
    Vyas A; Mantaian T; Kamat S; Kurian S; Kogut S
    J Geriatr Oncol; 2021 Sep; 12(7):1092-1099. PubMed ID: 34099411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and cost among patients treated for early-stage triple-negative breast cancer.
    Haiderali A; Rhodes WC; Gautam S; Huang M; Sieluk J; Skinner KE; Schwartzberg LS
    Future Oncol; 2021 Oct; 17(29):3833-3841. PubMed ID: 34254533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care.
    Hull LE; Lynch JA; Berse BB; DuVall SL; Chun DS; Venne VL; Efimova OV; Icardi MS; Kelley MJ
    Clin Breast Cancer; 2018 Apr; 18(2):135-143. PubMed ID: 29306660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women.
    Lairson DR; Parikh RC; Cormier JN; Chan W; Du XL
    Value Health; 2015 Dec; 18(8):1070-8. PubMed ID: 26686793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials.
    Hershman DL; Till C; Wright JD; Accordino M; Vaidya R; Barlow WE; Ramsey S; Unger JM
    Breast Cancer Res Treat; 2020 Jun; 181(2):455-463. PubMed ID: 32306168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-World Analysis of Medical Costs and Healthcare Resource Utilization in Elderly Women with HR+/HER2- Metastatic Breast Cancer Receiving Everolimus-Based Therapy or Chemotherapy.
    Hao Y; Li N; Fang AP; Koo V; Peeples M; Kageleiry A; Wu EQ; Guérin A
    Adv Ther; 2016 Jun; 33(6):983-97. PubMed ID: 27216253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States.
    Poorvu PD; Vaz-Luis I; Freedman RA; Lin NU; Barry WT; Winer EP; Hassett MJ
    Breast Cancer Res Treat; 2018 Apr; 168(3):727-737. PubMed ID: 29332137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient survival and healthcare utilization costs after diagnosis of triple-negative breast cancer in a United States managed care cancer registry.
    Baser O; Wei W; Henk HJ; Teitelbaum A; Xie L
    Curr Med Res Opin; 2012 Mar; 28(3):419-28. PubMed ID: 22364568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receipt of Guideline-Concordant Care Among Older Women With Stage I-III Breast Cancer: A Population-Based Study.
    LeMasters T; Madhavan SS; Sambamoorthi U; Hazard-Jenkins HW; Kelly KM; Long D
    J Natl Compr Canc Netw; 2018 Jun; 16(6):703-710. PubMed ID: 29891521
    [No Abstract]   [Full Text] [Related]  

  • 14. Healthcare utilization, Medicare spending, and sources of patient distress identified during implementation of a lay navigation program for older patients with breast cancer.
    Rocque GB; Williams CP; Jones MI; Kenzik KM; Williams GR; Azuero A; Jackson BE; Halilova KI; Meneses K; Taylor RA; Partridge E; Pisu M; Kvale EA
    Breast Cancer Res Treat; 2018 Jan; 167(1):215-223. PubMed ID: 28900752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare Utilization and Costs During the Initial Phase of Care Among Elderly Women With Breast Cancer.
    Vyas A; Madhavan SS; Sambamoorthi U; Pan XL; Regier M; Hazard H; Kalidindi S
    J Natl Compr Canc Netw; 2017 Nov; 15(11):1401-1409. PubMed ID: 29118232
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical and economic burden associated with stage III to IV triple-negative breast cancer: A SEER-Medicare historical cohort study in elderly women in the United States.
    Schwartz KL; Simon MS; Bylsma LC; Ruterbusch JJ; Beebe-Dimmer JL; Schultz NM; Flanders SC; Barlev A; Fryzek JP; Quek RGW
    Cancer; 2018 May; 124(10):2104-2114. PubMed ID: 29505670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women.
    Gauthier G; Gagnon-Sanschagrin P; Guérin A; Burne R; Small T; Niravath P; Dalal AA
    Adv Ther; 2018 Apr; 35(4):503-514. PubMed ID: 29556908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of guideline-concordant care with survival, health care utilization, and costs among older women with advanced epithelial ovarian cancer.
    Kamat S; Brown BR; Hume A; Vyas A
    Am J Manag Care; 2023 Oct; 29(10):e292-e298. PubMed ID: 37870550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to and persistence with adjuvant hormone therapy, healthcare utilization, and healthcare costs among older women with breast cancer: A population-based longitudinal cohort study.
    Zheng D; Thomas J
    J Geriatr Oncol; 2023 Nov; 14(8):101599. PubMed ID: 37598659
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.